Clinical Trial

Midodrine Use in Septic Shock

Study Description

Midodrine Use in Septic Shock

The investigators aim to perform a randomized, double-blind, placebo-controlled trial to investigate the efficacy of midodrine in decreasing time to IV vasopressor liberation in patients with septic shock.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Midodrine Hydrochloride

Midodrine Hydrochloride, enteral, 10 or 20 mg

placebo

investigational pharmacy formulated placebo comparator

Additional Information

Official Study Title

Midodrine Use for Hypotension Requiring IV Vasopressor Therapy in Early Septic Shock

Clinical Trial ID

NCT03706053

ParticipAid ID

eVOQMa